TNYA is trading at $0.65 (down 7.1%), extending last week’s volatility and breaking below the $0.70 level.
- The move appears to be a continuation of recent weakness driven by a broader risk-off market environment rather than a new company-specific catalyst.
- No fresh news, regulatory filings, or analyst updates have been released for Tenaya Therapeutics overnight.
- The stock remains under pressure as it continues to see a lack of support following recent price fluctuations.